Current Research Opportunities
ADMET – II
Apathy in Dementia Methylphenidate Trial 2
Sponsored by the National Institute on Aging (NIA), this research study examines the effectiveness of using an ADHD medication to improve cognition, interest, and emotion in those with Alzheimer’s Disease.
ADNI – 3
Federally-funded, ADNI (Alzheimer’s Disease Neuroimaging Initiative) examines historic brain aging through imaging, in the hopes of better understanding how Alzheimer’s Disease functions.
ADNI – DoD
Sponsored by the Department of Defense, this research study examines brain aging in Vietnam War Veterans as it correlates to Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD) that may be associated with a greater risk of Alzheimer’s Disease.
Sponsored by HOFFMAN/LaROCHE Pharmaceuticals, this study evaluates the efficacy and safety of an investigational medication in those with early/mild Alzheimer's Disease.
Funded by the National Institute on Aging (NIA), this study assesses investigational medical treatment, in addition to psychosocial intervention, as it correlates to agitation in Alzheimer’s Disease.
Sponsored by Biogen Pharmaceuticals, this study evaluates the safety and tolerability of an investigational medicine in participants with mild to moderate Alzheimer’s Disease.
Sponsored by Genentech, a member of the Roche Group, this study assesses safety, tolerability, and efficacy of an experimental medication in people with early to mild signs of Alzheimer’s Disease.
Sponsored by Biohaven, in conjunction with ADCS, this study assesses safety, tolerability, and efficacy of an experimental medication in people with mild to moderate Alzheimer’s Disease.
For more information, or to sign up for a study, please visit: https://www.alz.org/research/clinical_trials/find_clinical_trials_trialmatch.asp